Skip to main content
. 2021 Apr 19;138(2):149–159. doi: 10.1182/blood.2020009813

Table 2.

Time to first therapy and overall survival according to the CLL-IPI risk score among MBL and Rai 0 CLL

CLL-IPI Time to first therapy
Estimated 5-y risk Estimated 10-y risk
MBL, % Rai 0 CLL, % MBL, % Rai 0 CLL, % MBL vs CLL, P
Low 7.1 18.6 14.9 33.7 .002
Intermediate 13.4 40.8 49.0 67.7 <.0001
High 43.0 74.3 75.1 81.9 .02
Very high 0.0 57.8 0.0 Not estimable .09
CLL-IPI Overall survival
Estimated 5-y risk Estimated 10-y risk
MBL, % Rai 0 CLL, % MBL, % Rai 0 CLL, % MBL vs CLL, P
Low 95.3 97.1 82.4 80.7 .98
Intermediate 94.2 89.8 72.8 67.9 .55
High 83.6 77.1 62.4 46.0 .14
Very high 75.0 26.9 75.0 13.5 .36

Values in bold indicate P < .05.